Literature DB >> 11442576

Spectral analysis of heart rate variability and respiration during sleep in cocaine-exposed neonates.

M G Regalado1, V L Schechtman, M C Khoo, X D Bean.   

Abstract

This study's objective was to examine the autonomic control of heart rate and respiration during the neonatal period in human infants with prenatal exposure to cocaine. Four-hour daytime recordings of the electrocardiogram (ECG) were obtained from 15 cocaine-exposed and 13 non-exposed full-term neonates at 2 weeks of age during quiet sleep (QS) and active sleep (AS). For each 1-min epoch of sleep, the power spectrum of the R-R intervals was computed from the ECG to obtain the total power (0-2 Hz), and spectral power in the high-frequency (HFP, 0.3-2 Hz), mid-frequency (MFP, 0.1-0.2 Hz), and low-frequency (LFP, 0.03-0.1 Hz) bands. Respiration was also monitored and processed using similar spectral analysis procedures. Cocaine-exposed neonates showed enhanced heart rate variability reflected by an increase in spectral power across all frequency bands. Spectral power in LFP and MFP was higher in cocaine-exposed neonates during both sleep states, but only in HFP during QS. There were no respiratory patterning differences between the groups to account for these findings. The index of sympathovagal balance (LFP + MFP)/HFP, showed no differences between the groups. We conclude that infants exposed to cocaine in utero show differences in the modulation of heart rate reflecting an increase in both vagal and sympathetic influences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442576     DOI: 10.1046/j.1365-2281.2001.00353.x

Source DB:  PubMed          Journal:  Clin Physiol        ISSN: 0144-5979


  14 in total

1.  Autonomic functioning among cocaine-exposed kindergarten-aged children: Examination of child sex and caregiving environmental risk as potential moderators.

Authors:  Pamela Schuetze; Rina D Eiden; Shannon Shisler
Journal:  Neurotoxicol Teratol       Date:  2020-04-28       Impact factor: 3.763

2.  Behavior problems among cocaine exposed children: role of physiological regulation and parenting.

Authors:  Brent Finger; Pamela Schuetze; Rina D Eiden
Journal:  Neurotoxicol Teratol       Date:  2014-01-28       Impact factor: 3.763

3.  The association between maternal cocaine use during pregnancy and physiological regulation in 4- to 8-week-old infants: an examination of possible mediators and moderators.

Authors:  Pamela Schuetze; Rina D Eiden
Journal:  J Pediatr Psychol       Date:  2005-03-23

4.  Prenatal cocaine and other substance exposure: effects on infant autonomic regulation at 7 months of age.

Authors:  Pamela Schuetze; Rina D Eiden; Claire D Coles
Journal:  Dev Psychobiol       Date:  2007-04       Impact factor: 3.038

Review 5.  Short- and long-term adverse effects of cocaine abuse during pregnancy on the heart development.

Authors:  Kurt D Meyer; Lubo Zhang
Journal:  Ther Adv Cardiovasc Dis       Date:  2009-02

6.  Profiles of Reactivity in Cocaine-Exposed Children.

Authors:  Pamela Schuetze; Danielle S Molnar; Rina D Eiden
Journal:  J Appl Dev Psychol       Date:  2012-10-11

7.  A Longitudinal Examination of Physiological Regulation in Cocaine-Exposed Infants Across the First 7 Months of Life.

Authors:  Pamela Schuetze; Rina D Eiden; Ellen P Edwards
Journal:  Infancy       Date:  2009-01-01

8.  The association between prenatal cocaine exposure and physiological regulation at 13 months of age.

Authors:  Pamela Schuetze; Rina D Eiden; Susan Danielewicz
Journal:  J Child Psychol Psychiatry       Date:  2009-09-09       Impact factor: 8.982

9.  Physiological Regulation at 9 Months of Age in Infants Prenatally Exposed to Cigarettes.

Authors:  Pamela Schuetze; Rina D Eiden; Craig R Colder; Teresa R Gray; Marilyn A Huestis
Journal:  Infancy       Date:  2013

10.  Emotional arousal in cocaine exposed toddlers: prediction of behavior problems.

Authors:  Tara M Chaplin; Thomas Fahy; Rajita Sinha; Linda C Mayes
Journal:  Neurotoxicol Teratol       Date:  2009-05-21       Impact factor: 3.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.